Kaiser Drugs Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 28-07-2024
- Paid Up Capital ₹ 1.42 M
as on 28-07-2024
- Company Age 25 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.20 M
as on 28-07-2024
- Revenue -9.52%
(FY 2023)
- Profit -54.98%
(FY 2023)
- Ebitda -24.18%
(FY 2023)
- Net Worth 20.88%
(FY 2023)
- Total Assets 7.47%
(FY 2023)
About Kaiser Drugs
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.42 M.
The company currently has active open charges totaling ₹2.20 M.
Vijay Agarawal, Naresh Agarwal, Archana Agarwal, and One other member serve as directors at the Company.
- CIN/LLPIN
U85110UP1999PTC024379
- Company No.
024379
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Apr 1999
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Kaiser Drugs Private Limited offer?
Kaiser Drugs Private Limited offers a wide range of products and services, including Common Disease Medicines, Antihistamines, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Antibacterial Drugs, Ayurvedic,Herbal Products & Medicine, Ayurvedic Herbal Syrups & Tonics, Nutraceuticals & Dietary Supplements, Multivitamin Syrup & Drops, Pain Relief Drugs & Pharmaceuticals.
Who are the key members and board of directors at Kaiser Drugs?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vijay Agarawal  | Director | 26-Apr-1999 | Current |
| Naresh Agarwal | Director | 26-Apr-1999 | Current |
| Archana Agarwal | Director | 26-Apr-1999 | Current |
| Dinesh Agarwal | Director | 26-Apr-1999 | Current |
Financial Performance of Kaiser Drugs.
Kaiser Drugs Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 9.52% decrease. The company also saw a substantial fall in profitability, with a 54.98% decrease in profit. The company's net worth Soared by an impressive increase of 20.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kaiser Drugs?
In 2023, Kaiser Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 03 May 2012 | ₹1.20 M | Open |
Union Bank Of India Creation Date: 27 Dec 2002 | ₹1.00 M | Open |
How Many Employees Work at Kaiser Drugs?
Kaiser Drugs has a workforce of 26 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kaiser Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kaiser Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
